64th Annual Biosafety and Biosecurity Hybrid Conference
Scientific Program
October 25-27, 2021
October 25, 2021
Monday Morning
8:00 – 8:50 am
9:00 – 4:00 pm Vendor Exhibits
8:00 – 8:30 am – Welcome Video from the ABSA International President
8:30 – 8:45 am – Welcome and ABSA International President’s Address
Master of Ceremonies: Melissa A. Mørland, MS, MBA, RBP(ABSA), CBSP(ABSA), SM(NRCM), University of Maryland—Baltimore, Baltimore, MD
8:45 – 8:50 am – Scientific Program Committee Welcome
Claudia Gentry-Weeks, PhD, CBSP(ABSA), Colorado State University, Fort Collins, CO
Session I – Invited Speaker
8:50 – 9:50 am
Introduction: Cristine Lawson, PhD, RBP(ABSA), CBSP(ABSA), U.S. Department of Defense, Fort Detrick, MD
Moderator: George Wudiri, PhD, Sandia National Laboratories, Albuquerque, NM
8:50 – 9:30 am – Virology in the Time of a Pandemic
Dirk P. Dittmer, PhD, University of North Carolina—Chapel Hill, Chapel Hill, NC
9:30 – 9:50 am – Session I Q&A Session
Exhibits and Posters
9:50 – 10:20 am
Session II – Response to COVID-19
10:20 – 11:50 am
Moderators: Darlene Ward, RBP(ABSA), Advarra, Boca Raton, FL James Baugh, PhD, RBP(ABSA), CBSP(ABSA), University of California—Davis, Davis, CA
10:20 – 10:35 am – Short Term Use Biocontainment Bubbles—Innovative Source Containment of Potentially Infectious SARS-CoV-2 Aerosols
Benjamin Fontes, MS, CBSP(ABSA), Yale University, New Haven, CT
10:35 – 10:50 am – Pandemic Response Team (PRT)—A Systematic Approach to Ensure Business Continuity Amid Major Disaster
Hsiang-Ming Wang, PhD, MBA, CBSP(ABSA), Texas Biomedical Research Institute, San Antonio, TX
10:50 – 11:05 am – Modeling the Stability of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) on Skin, Clothing, Currency, Produce, and Personal Protective Equipment (PPE) Across Different Temperatures
David Harbourt, PhD, RBP(ABSA), CBSP(ABSA), Food and Drug Administration, Laurel, MD
11:05 – 11:20 am – Lessons Learned from Biosafety with COVID-19 Vaccines
Chris Jenkins, MPH, PhD, RBP(ABSA), Clinical Biosafety Services, Wildwood, MO
11:20 – 11:50 pm – Session II Q&A Session
Session III – Arnold G. Wedum Memorial Lecture Award
11:50 am – 12:50 pm
Introduction: Jessica McCormick-Ell, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), National Institutes of Health, Bethesda, MD
Moderator: Larry Mendoza, RBP(ABSA), Virginia Commonwealth University, Richmond, VA
11:50 am – 12:35 pm – The COVID Pandemic: The Evolving Reality
Michael T. Osterholm, PhD, MPH, CIDRAP, University of Minnesota, Minneapolis, MN
12:35 – 12:50 pm- Session III Q&A Session
Exhibits, Posters, and Lunch
12:50 pm – 2:00 pm
Session IV Networking Groups
2:00 – 3:00 pm
Exhibits and Posters
3:00 – 3:30 pm
Session V – Inactivation and Decontamination
3:30 – 5:00 pm
Moderators: Michael Chute, RBP(ABSA), U.S. Department of Defense, Fort Detrick, MD Shelley Jones, MS, RBP(ABSA), Northern Arizona University, Flagstaff, AZ
3:30 – 3:45 pm – Validation of Poliovirus Inactivation by Nucleic Acid Extraction Buffers
Michelle Honeywood, PhD, Centers for Disease Control and Prevention, Atlanta, GA
3:45 – 4:00 pm – Trials and Tribulations: The Commissioning and Validation of a Chemical Effluent Decontamination System using Bacillus Atrophaeus Spore Strips
Rachel Gamble, DrPh, CBSP(ABSA), Merrick & Company, Washington, DC
4:00 – 4:15 pm – Mechanisms of Sporicidal Activity Induced by Ionized Hydrogen Peroxide in the Inactivation of Spores of Bacillus Atrophaeus and Geobacillus Stearothermophilus
Miguel Grimaldo, MEng, DSc, University of Texas Medical Branch—Galveston, Galveston, TX
4:15 – 4:30 pm – Compatibility of Materials with Decontaminating and Disinfecting Agents
Lauren Richardson, DVM, MPH, DACVPM, Merrick & Company, Washington, DC
4:30 – 5:00 pm – Session V Q&A Session
October 26, 2021
Tuesday Morning
7:00 – 9:05 am
9:00 – 4:00 pm Vendor Exhibits
8:15 – 8:30 am – Award Announcement
TBD
Session VI – Business Continuity Roundtable
8:30 – 9:30 am
Moderator: AJ Troiano, PhD, RBP(ABSA), Scorton Creek Biosafety, LLC, East Sandwich, MA
Daniel Eisenman, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), Advarra, Research Triangle Park, NC James Riddle, MCSE, CIP, CPIA, CRQM, Advarra, Columbia, MD Dennis Nolan, MPH, RBP(ABSA), CBSP(ABSA), Baylor University, Waco, TX Sylvie Blondelle, PhD, RBP(ABSA), Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA Julianne Baron, PhD, RBP(ABSA), CPH, Science and Safety Consulting, LLC, McMurray, PA
Session VII – Griffin Lecture Award
9:30 – 10:50 am
Introduction: Erin Sorrell, PhD, Elizabeth R. Griffin Program, Georgetown University Medical Center, Washington, DC
Moderator: Francine Rogers, ALM, MS, RBP(ABSA), CBSP(ABSA), SM(NRCM), Massachusetts Ear and Eye, Boston, MA
9:30 – 10:15 am – Biosafety, COVID-19, and What Comes Next
Gigi Kwik Gronvall, PhD, Johns Hopkins Center for Health Security, John Hopkins Bloomberg School of Public Health, Baltimore, MD
10:15 – 10:30 am – Session VII Q&A Session
Exhibits and Posters
10:30 – 10:50 am
Session VIII – Innovations in Laboratory Practices
10:50 – 11:50 am
Moderators: George Wudiri, PhD, Sandia National Laboratories, Albuquerque, NM Darlene Ward, RBP(ABSA), Advarra, Boca Raton, FL
10:50 – 11:05 am – BSC Mythbusters: Appropriate Placement of a Particle Counter Probe in a Class II BSC
Kara Held, PhD, Baker, Sanford, ME
11:05 – 11:20 am – Lessons Learned from the Attempt to Develop a Respirator During a Pandemic
Jason Keaton, MS, RBP(ABSA), CBSP(ABSA), CSP, Shield Consulting, Milwaukee, WI
11:20 – 11:35 am – Challenges and Lessons Learned from the COVID-19 Pandemic
Peili Zhu, PhD, RBP(ABSA), University of California—San Francisco, San Francisco, CA
11:35 – 11:50 am – Session VIII Q&A Session
Session IX – Networking Groups
11:55 am – 12:55 pm
Exhibits, Posters, and Lunch
12:55 – 1:55 pm
Session X – Eagleson Lecture Award
1:55 – 2:55 pm
Introduction: Mary Ann Sondrini, Eagleson Institute, Sanford, ME
Moderator: Kalpana Rengarajan, MPH, PhD, JM, RBP(ABSA), Emory University, Atlanta, GA
1:55 – 2:40 pm – Update on COVID-19 Vaccines
Nadine Rouphael, PhD, Emory University School of Medicine, Atlanta, GA
2:40 – 2:55 pm – Session X Q&A Session
Session XI – High Containment
2:55 – 3:55 pm
Moderators: Maya Nair, RBP(ABSA), University of North Texas Health Science Center, Fort Worth, TX Sunny Hoffman, RBP(ABSA), Clinical Biosafety Services, Columbia, MO
2:55 – 3:10 pm – In Vivo PET/CT Imaging in an ABSL-3 Non-Human Primate (NHP) Facility
Beata Clapp, PhD, Texas Biomedical Research Institute, San Antonio, TX
3:10 – 3:25 pm – Facility Upgrades to a High-Containment Laboratory—Risk Mitigation and Engineering Controls
Fahim Manzur, MS, Plum Island Animal Disease Center, Orient Point, NY
3:25 – 3:40 pm – Maintaining and Rapidly Expanding High Containment Operations During a Pandemic
John Henneman, MS, RBP(ABSA), Kansas State University, Manhattan, KS
3:40 – 3:55 pm – Session XI Q&A Session
Exhibits and Posters
3:55 – 4:15 pm
Session XII – Gene Therapy and GMOs
4:15 – 5:15 pm
Moderators: Peili Zhu, PhD, RBP(ABSA), University of California—San Francisco, San Francisco, CA Michael McCarthy, RBP(ABSA), CHMM, Vertex Pharmaceuticals, Cambridge, MA
4:15 – 4:35 pm – The Current Gene Therapy Research Boom and Future Challenges
Daniel Eisenman, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), Advarra, Research Triangle Park, NC
4:35 – 4:55 pm – Recombinant Technologies with Vaccine Production
Justin Roth, PhD, RBP(ABSA), University of Alabama—Birmingham/Advarra, Birmingham, AL
4:55 – 5:15 pm – Session XII Q&A Session
October 27, 2021
Wednesday Morning
7:00 – 8:05 am
9:00 – 4:00 pm – Vendor Exhibits
8:15 – 8:30 am – Awards Announcement
TBD
Session XIII – Biorisk Program Management
8:30 – 9:30 am
Moderators: Julianne Baron, PhD, RBP(ABSA), CPH, Science and Safety Consulting, LLC, McMurray, PA Michael McCarthy, RBP(ABSA), CHMM, Vertex Pharmaceuticals, Cambridge, MA
8:30 – 8:50 am – Achieving Laboratory Biosafety Standards in a Resource Limited Setting in the Face of COVID-19 Pandemic: The Nigeria Center for Disease Control National Reference Laboratory (NRL) Experience
Olubunmi Ruth Negedu-Momoh, PhD, Nigeria Center for Disease Control, Public Health England International Health Regulations (IHR) Strengthening Program, Abuja, Nigeria
8:50 – 9:10 am – Biological Toxins: Surveying the Institutional Wild West
Antony Schwartz, PhD, CBSP(ABSA), SM(NRCM), Duke University | Duke University Health System, Durham, NC
9:10 – 9:30am
Session XI Q&A Session
Session XIV – Regulations and Emerging Topics
9:30 – 10:30 am
Moderators: Francine Rogers, ALM, MS, RBP(ABSA), CBSP(ABSA), SM(NRCM), Massachusetts Ear and Eye, Boston, MA Sunny Hoffman, RBP(ABSA), Clinical Biosafety Services, Columbia, MO
9:30 – 9:50 am – What’s New from the NIH Office of Science Policy
Kathryn Harris, PhD, RBP(ABSA), National Institutes of Health, Bethesda, MD
9:50 – 10:10 am – Intersection of Infection Control and Biosafety
Patrick Conley, CBSP(ABSA), Clinical Biosafety Services, Keller, TX
10:10 – 10:30 am – Session XIV Q&A Session
Exhibits and Posters
10:30 – 10:50 am
Session XV – Poliovirus Containment Roundtable
Moderators: Claudia Gentry-Weeks, PhD, CBSP(ABSA), Colorado State University, Fort Collins, CO Cristine Lawson, PhD, CBSP(ABSA), U.S. Department of Defense, Fort Detrick, MD
10:50 pm – 12:20 pm
Panelists:
Status of the Revision of the World Health Organization Global Action Plan III for Poliovirus Containment
Liliane Boualam, MPH, World Health Organization, Geneva, Switzerland
Preparation for Poliovirus Containment in the United States: A National Inventory for Poliovirus Infectious and Potentially Infectious Materials, 2002-2021
Cecelia Sanders, MPA, Centers for Disease Control and Prevention, Atlanta, GA
Improving Risk-based Decision Making for Poliovirus Containment
LouAnn Burnett, MS, CBSP(ABSA), Sandia National Laboratories, Albuquerque, NM
Global Action Plan III (GAPIII) Exit Shower vs Enhanced Personal Protective Equipment: An Evidence-based Risk Model to Help Prevent a Facility-associated Release of Poliovirus
Ryan Ritterson, PhD, Gryphon Scientific, Takoma Park, MD
Exhibits, Posters, and Lunch
12:20 – 1:20 pm
Session XVI – Richard Knudsen Award
1:20 – 1:50 pm
Moderator: Colleen Kovacsics, PhD, RBP(ABSA), Spark Therapeutics, Philadelphia, PAD
1:20 – 1:50 pm – TBD
Session XVII – Behavior and Biosafety
1:50 – 2:50 pm
Moderators: Kalpana Rengarajan, MPH, PhD, JM, RBP(ABSA), Emory University, Atlanta, GA Kelly Flint, RBP(ABSA), CBSP(ABSA), SM(NRCM), National Institutes of Health, Fort Detrick, MD
1:50 – 2:05 pm – Behavioral Biosafety
David Bryant, MHL, Animal & Plant Health Agency (APHA), Addlestone, United Kingdom
2:05 – 2:20 pm – Biosafety Climate (BSCL) in Biological and Biomedical Laboratories at Public Universities in the USA
Sivarchana Mareedu, PhD (candidate), University of Louisville, Louisville, KY
2:20 – 2:35 pm – Are You Using Your Safety Eyes?
Dan Scungio, BSMT, MT(ASCP), CQA(ASQ), Dan the Lab Safety Man, Inc., Williamsburg, VA
2:35 – 2:50 pm – Session XVII Q&A Session
Exhibits and Posters
2:50 – 3:10 pm
Session XVIII – Biosafety Culture Roundtable
3:10 – 4:10 pm
Moderators: James Baugh, PhD, RBP(ABSA), CBSP(ABSA), University of California—Davis, Davis, CA AJ Troiano, PhD, RBP(ABSA), Scorton Creek Biosafety, LLC, East Sandwich, MA
Caren Wenner, PhD, Sandia National Laboratories, Albuquerque, NM Jessica Martin, PhD, University of Connecticut, Storrs, CT Shane Gillooly, MS, RBP(ABSA), CBSP(ABSA), University of Miami, Coral Gables, FL
Session XIX – Agriculture and Animal Biosafety
4:10 – 5:10 pm
Moderators: Matthew Anderson, PhD, RBP(ABSA), CBSP(ABSA), University of Nebraska—Lincoln, Lincoln, NE Noman Siddiqi, PhD, RBP(ABSA), Harvard School of Public Health, Boston, MA
4:10 – 4:30 pm – SARS-CoV-2 and Its Impact on Agriculture
David Suarez, DVM, PhD, USDA Southeast Poultry Research Lab, Athens, GA
4:30 – 4:50 pm – Plant Biosafety and Risk Assessment
Deborah Howard, MPH, CBSP(ABSA), BASF, Research Triangle Park, NC
4:50 – 5:10 pm – Session XIX Q&A Session
Close of Conference
5:10 – 5:25 pm
Past President: Melissa A. Mørland, MS, MBA, RBP(ABSA), CBSP(ABSA), SM(NRCM), University of Maryland—Baltimore, Baltimore, MD President: LouAnn Burnett, MS, CBSP(ABSA), Sandia National Laboratories, Albuquerque, NM